These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1513579)

  • 21. Clinical use of recombinant plasminogen activator for intraocular fibrinolysis.
    Koerner F; Boehnke M
    Ger J Ophthalmol; 1992; 1(5):354-60. PubMed ID: 1477641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracameral tissue plasminogen activator to prevent severe fibrinous effusion after congenital cataract surgery.
    Siatiri H; Beheshtnezhad AH; Asghari H; Siatiri N; Moghimi S; Piri N
    Br J Ophthalmol; 2005 Nov; 89(11):1458-61. PubMed ID: 16234453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The use of tissue plasminogen activator in the post-operative treatment of fibrinoid uveitis].
    Chiseliţă D; Antohi I; Cionca D; Medvichi R; Cimpoeşu D
    Oftalmologia; 2006; 50(2):68-72. PubMed ID: 16927762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracameral tissue plasminogen activator use in a large series of eyes with valved glaucoma drainage implants.
    Zalta AH; Sweeney CP; Zalta AK; Kaufman AH
    Arch Ophthalmol; 2002 Nov; 120(11):1487-93. PubMed ID: 12427061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracameral injection of tissue plasminogen activator to treat severe postoperative fibrinous reaction in iridocorneal endothelial syndrome.
    Hong BK; Francis BA
    Digit J Ophthalmol; 2013; 19(2):21-3. PubMed ID: 24109245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The South Asian cataract management study: complications, vision outcomes, and corneal endothelial cell loss in a randomized multicenter clinical trial comparing intracapsular cataract extraction with and without anterior chamber intraocular lens implantation.
    Snellingen T; Shrestha JK; Huq F; Husain R; Koirala S; Rao GN; Pokhrel RP; Kolstad A; Upadhyay MP; Apple DJ; Arnesen E; Cheng H; Olsen EG; Vogel M
    Ophthalmology; 2000 Feb; 107(2):231-40. PubMed ID: 10690817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Etiology of corneal opacities after plasminogen activator-induced fibrinolysis of the anterior chamber].
    Hesse L; Nebeling B; Kauffmann T
    Ophthalmologe; 1999 Jul; 96(7):448-52. PubMed ID: 10479896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose tissue plasminogen activator in the management of anterior chamber fibrin formation.
    Georgiadis N; Boboridis K; Halvatzis N; Ziakas N; Moschou V
    J Cataract Refract Surg; 2003 Apr; 29(4):729-32. PubMed ID: 12686240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of anterior segment fibrinous reactions and hemorrhage with intracameral low dose rt-PA: clinical study and review of the literature].
    Le Rouic JF; Behar-Cohen F; Nghiem MH; Renard G; Chauvaud D
    J Fr Ophtalmol; 2000 Dec; 23(10):977-83. PubMed ID: 11139689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrin membrane pupillary-block glaucoma after uneventful cataract surgery treated with intracameral tissue plasminogen activator: a case report.
    Yoshino H; Seki M; Ueda J; Yoshino T; Fukuchi T; Abe H
    BMC Ophthalmol; 2012 Mar; 12():3. PubMed ID: 22433746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of intraocular fibrin formation with tissue plasminogen activator after vitrectomy].
    Zhao P; Wang W
    Zhonghua Yan Ke Za Zhi; 1995 Jul; 31(4):255-8. PubMed ID: 8745515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of recombinant tissue plasminogen activator in severe post-operative fibrinous reaction after uneventful phacoemulsification - a case series and review.
    Ibramsah AB; Cheong AI; Wan Muda WN; Ibrahim M
    Rom J Ophthalmol; 2022; 66(1):27-31. PubMed ID: 35531461
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of tissue plasminogen activator to revive blebs following intraocular surgery.
    Smith MF; Doyle JW
    Arch Ophthalmol; 2001 Jun; 119(6):809-12. PubMed ID: 11405830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of tissue plasminogen activator in postvitrectomy cases.
    Koutsandrea C; Apostolopoulos M; Theodossiadis P
    Int Ophthalmol; 1993 Apr; 17(2):95-100. PubMed ID: 8407122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrinolysis of postcataract fibrin membranes in children.
    Mehta JS; Adams GG
    J Cataract Refract Surg; 2000 Jan; 26(1):4-5. PubMed ID: 10646131
    [No Abstract]   [Full Text] [Related]  

  • 36. Intracameral tissue plasminogen activator after glaucoma surgery. Indications, effectiveness, and complications.
    Lundy DC; Sidoti P; Winarko T; Minckler D; Heuer DK
    Ophthalmology; 1996 Feb; 103(2):274-82. PubMed ID: 8594514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re-forming the flat anterior chamber with Healon.
    Osher RH; Cionni RJ; Cohen JS
    J Cataract Refract Surg; 1996 May; 22(4):411-5. PubMed ID: 8733842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Long-term follow-up of flexible open-loop anterior chamber intraocular lenses implantation].
    Huang YS; Xie LX; Wu XM; Han DS
    Zhonghua Yan Ke Za Zhi; 2006 May; 42(5):391-5. PubMed ID: 16762230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of tissue plasminogen activator in experimental hyphema.
    Lambrou FH; Snyder RW; Williams GA
    Arch Ophthalmol; 1987 Jul; 105(7):995-7. PubMed ID: 3111453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant tissue plasminogen activator following paediatric cataract surgery.
    Mehta JS; Adams GG
    Br J Ophthalmol; 2000 Sep; 84(9):983-6. PubMed ID: 10966949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.